Lates News

Nanxin Pharmaceutical: The company is currently planning to acquire certain domestic assets, such as pharmaceutical technology, but it is not yet certain whether this will constitute a major asset restructuring. The matter is still in the planning stage, and no intention agreement related to the acquisition has been signed. There is significant uncertainty as to whether the implementation can proceed smoothly.